Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Herpes Simplex

• Hand Sanitizer Use for Herpes Simplex Virus-1
• Acyclovir in Mechanically Ventilated Patients With Pneumonia and HSV-1 in BAL
• Efficacy of Lazolex® Gel in the Treatment of Herpes Simplex
• Non-inferiority Study of ZK-A03 in Treatment of Herpes Zoster Before and After the Alteration of the Active Ingredient Manufacturer
• A Clinical Study of Freshly Manufactured 35kDa Hyaluronan Fragment in the Treatment of Pain
• A Study to Evaluate Safety and Tolerability of a Recombinant Herpes Zoster Vaccine
• Thorough QT/QTc of Pritelivir in Healthy Subjects
• Vitamin C as add-on Therapy in Patients With Acute Herpes Zoster
• Phase I Trial to Evaluate the Potential Influence of Pantoprazole on the Pharmacokinetics of Pritelivir
• A Study Exploring Efficacy of Peginterferon in Patients With Herpes Zoster
• A Phase 3 Study of NPC-06 in Patients With Pain Associated With Acute Herpes Zoster
• Neonatal Phase 1 Valacyclovir Study
• Aciclovir Versus Placebo for HSV-2 Meningitis
• A Study on the Reactogenicity, Safety, Immune Response, and Efficacy of a Vaccine Against HSV-2 in Healthy Participants Aged 18-40 Years or in Participants Aged 18-60 Years With Recurrent HSV-2 Genital Herpes
• EDTA Eye Drops Compared to Abreva for Herpes Simplex Virus Eruptions
• A Study on the Reactogenicity, Safety and Immune Response of a Vaccine Against Herpes Simplex Virus (HSV)-2 in Healthy Participants Aged 18-40 Years
• Valacyclovir for Mild Cognitive Impairment
• Safety and Efficacy of CRISPR/Cas9 mRNA Instantaneous Gene Editing Therapy to Treat Refractory Viral Keratitis
• Valacyclovir in Neonatal Herpes Simplex Virus Disease
• Study of 2LHERP® in Genital Herpes Infections
• Pharmacokinetics of Valacyclovir Oral Solution in Children
• Randomized, Placebo-controlled, Double-blind Study of 2LHERP® in Orofacial Herpes Infections.
• Topical Corticosteroid Use in Addition to Oral Antivirals for Prevention of Recurrence of Herpes Simplex Virus (HSV) Keratitis
• Effectiveness and Clinical Mechanism of Huanglian-Jiedu Decoction in Patients With Intense-exuberant Stomach Fire Syndrome
• Anti-viral Therapy in Alzheimer's Disease
• Femtosecond Laser-assisted Corneal Debridement for Herpes Simplex Keratitis
• Dexamethasone in Herpes Simplex Virus Encephalitis
• Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Subjects
• Feasibility and Effects of Valaciclovir Treatment in Persons With Early Alzheimer's Disease
• Vaginal Antibody Safety Trial: Safety Study of Monoclonal Antibodies to Reduce the Vaginal Transmission of Herpes Simplex Virus (HSV) and Human Immunodeficiency Virus (HIV)
• HSV529 Vaccine in HSV-2 Seropositive Adults
• Evaluating New Formulation of Therapeutic HSV-2 Vaccine
• Antiviral Prophylaxis in a Burn Population
• Study to Evaluate Safety, Tolerability, and Pharmacokinetics of UB-621 in Healthy Volunteers
• Open-label Study of ASP2151 in Herpes Simplex Patients
• A Double-Blind, Randomized, Placebo-Controlled Study of Topical VDO for the Treatment of Herpes Simplex Labialis
• Dose Ranging Safety and Efficacy of Therapeutic HSV-2 Vaccine
• Phase III Study of ASP2151 in Herpes Simplex Patients
• Evaluation of Cold Sore Treatments on Ultra Violet (UV) Induced Cold Sores
• Valacyclovir Augmentation for Cognitive and Functional Remediation in Schizophrenia
• Bioequivalence Study in Healthy Volunteers of a New Paediatric Formulation of Valacyclovir
• Biological Efficacy Study of HerpV Vaccine With QS-21 to Treat Participants With Recurrent Genital Herpes
• Palatability Testing of a New Paediatric Formulation of Valacyclovir
• A Safety and Dose-Determining Study of CMX001 In Infants With Neonatal Herpes Simplex Virus (HSV) Infection Involving the Central Nervous System (CNS Disease)
• Valaciclovir Hydrochloride Phase III for Hematopoietic Stem Cell Transplantation Patients
• Evaluating Three Grams Daily Valacyclovir in Patients With Chronic Hepatitis C and HSV-2 Infection (Phase I)
• Effect of Tenofovir on Genital Herpes Simplex Virus (HSV) Shedding
• Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
• Safety and Effectiveness of Tenofovir Gel in the Prevention of Human Immunodeficiency Virus (HIV-1) Infection in Women and the Effects of Tenofovir Gel on the Incidence of Herpes Simplex Virus (HSV-2) Infection
• A Multicenter Study of NB-001 in the Treatment of Recurrent Herpes Labialis
• Safety and Efficacy Study of a New Treatment for Recurrent Symptoms of Oral Herpes Virus Infection
• Can Valacyclovir Attenuate Inflammation in Antiretroviral-Treated HIV-Infected Individuals With Herpes Simplex Virus Type 2?
• Herpes Simplex Type 2 Co-infection in Veterans With Chronic Hepatitis C
• Valacyclovir vs. Acyclovir as HSV-2 Suppressive Therapy: Effect on Plasma HIV-1 Levels Among HIV-1/HSV-2 Co-infected Persons
• Examining the Ability of Herpes Simplex Virus Type 2 (HSV2) Therapy to Reduce HIV Target Cell Numbers in the Cervix
• A Study to Describe the Pharmacokinetics of Acyclovir in Premature Infants (PTN_Acyclo)
• A Randomized Double-Blind Control-Comparison Crossover Trial of Oral Glutamine to Suppress Frequently Recurrent Herpes Labialis
• Can Valacyclovir Delay the Need for Initiation of Human Immunodeficiency Virus (HIV) Treatment in HIV-infected Individuals?
• Acyclovir in Preventing Herpes Simplex Virus Infection in Patients With Neutropenia
• Zinc for the Treatment of Herpes Simplex Labialis (HSL)
• Study of ME-609 and Acyclovir for Treatment of Herpes Simplex Labialis in Immunocompromised Patients
• Valacyclovir Suppression to Improve the Stability of Vaginal Flora Among HSV-2 Seropositive Women
• 30-Day Trial of Oral Valtrex or Valtrex Plus Aspirin on Shedding of HSV DNA in Tears and Saliva of Volunteers
• HSV-2 Suppression to Reduce Maternal HIV-1 RNA Levels During Pregnancy and Breastfeeding
• Trial to Study the Effect of Dose of Herpes Simplex Virus-2 (HSV-2) Suppressive Therapy on HSV and HIV
• HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1 Co-infected Persons
• Asymptomatic Bacterial Vaginosis and Herpes Simplex Virus Type 2 (BV/HSV-2) Shedding Study
• Pharmacokinetics, Acceptability and Safety of Famciclovir in Infants (1 Month to Less Than 12 Months) With Herpes Simplex Infection
• HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1, HSV-2 Co-infected Men.
• Safety Study of ME-609 for Treatment of Herpes Simplex Labialis in Adolescents
• Effectiveness of Acyclovir in Suppressing HIV Viral Load in Women Coinfected With HIV and Herpes Simplex Virus Type 2 (HSV-2)
• Efficacy and Safety Study of ME-609 and Acyclovir for Treatment of Herpes Simplex Labialis
• VivaGel™ in Healthy Young Women
• A Safety And Tolerability Study Of Valaciclovir Oral Suspension In Infants And Children
• Safety, Acceptability and Preliminary Effectiveness of PC-515 for Vaginal Use as a Possible Microbicide
• Herpes Simplex Virus Type 2 (HSV-2) Suppression to Prevent HIV Transmission
• Episodic Acyclovir Therapy for Genital Ulcers
• A Study of Valacyclovir to Suppress HSV and HIV Shedding in Coinfected Persons
• Famciclovir Pediatric Formulation in Children 1 to 12 Years of Age With Herpes Simplex Infection
• Long Term Treatment of Herpes Simplex Encephalitis (HSE) With Valacyclovir
• Acyclovir for Herpes Infections Involving the Central Nervous System in Neonates
• Acyclovir Herpes Simplex Virus (HSV) Skin, Eye, and Mouth
• Phase III Randomized Study of Oral Acyclovir in Infants With Herpes Simplex Virus Infection Limited to Skin, Eyes, and Mouth
• Phase III Randomized Study of Oral Acyclovir in Infants With Herpes Simplex Virus Infection Involving the Central Nervous System
• A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected Patients
• Phase III Randomized, Placebo-Controlled Study of Acyclovir Oral Suspension for Neonatal Herpes Simplex Virus Infection Limited to the Skin, Eyes, and Mouth
• Phase I/II Study of High-Dose Acyclovir for Central Nervous System or Disseminated Neonatal Herpes Simplex Virus Infection
• The Effect of Valacyclovir on the Detection of HIV From Genital Herpes Lesions in HIV-Infected Patients
• SP-303T Applied to the Skin of Patients With Herpes Simplex Virus (HSV) Infection and AIDS Who Have Not Had Success With Acyclovir
• An Open, Multicenter Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other Immunodeficiencies
• Double-Blind Placebo-Controlled Study Comparing the Combination of 15% SP-303 Gel With Acyclovir Versus Acyclovir Alone for the Treatment of Recurrent Herpes Simplex Virus (HSV) Infections in Subjects With Acquired Immunodeficiency Syndrome (AIDS)
• Cidofovir as a Treatment for Herpes Simplex in Patients With AIDS
• The Pilot Study of Foscarnet Cream in the Treatment of Mucocutaneous Herpes Simplex Virus Infections in Immunocompromised Patients Unresponsive to Acyclovir Treatment
• A Phase I/II Study of the Safety and Efficacy of Topical 1-(S)-(3-Hydroxy-2-Phosphonylmethoxypropyl)Cytosine Dihydrate (Cidofovir; HPMPC) in the Treatment of Refractory Mucocutaneous Herpes Simplex Disease in Patients With AIDS
• A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected Patients
• An Open Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other Immunodeficiencies
• A Study to Compare the Efficacy and Safety of Valacyclovir Hydrochloride ( 256U87 ) Versus Acyclovir in the Treatment of Recurrent Anogenital Herpes Infections in HIV Infected Patients
• Valaciclovir to Prevent Transmission of Herpes Simplex Virus
• The Effect of Acyclovir Treatment of the Herpes Simplex Virus (HSV) Infection on HIV Levels in the Blood
• The Safety and Effectiveness of Valacyclovir HCl in the Treatment of Herpes Simplex or Varicella/Zoster Infections in HIV-1 Infected Children
• Comparison of Foscarnet Versus Vidarabine in the Treatment of Herpes Infection in Patients With AIDS Who Have Not Had Success With Acyclovir
• The Tolerance of HIV-Infected Patients With Herpes Group Virus Infections to Oral Doses of FIAU
• Treatment of Acyclovir-Resistant Mucocutaneous Herpes Simplex Disease in Patients With AIDS: Open Label Pilot Study of Topical Trifluridine
• Herpetic Eye Disease Study (HEDS) II
• Herpetic Eye Disease Study (HEDS) I